论文部分内容阅读
在大多数心肌梗塞(MI)后危险度分层和干预试验中,心原性死亡被单独或与非致死性心肌再梗塞共同作为主要转归终点,但非致死性再梗塞对于随后的心原性死亡所构成的危险性缺乏定量研究。本文探讨心原性死亡和非致死性再梗塞的临床决定因素,确定非致死性再梗塞对于随后的心原性死亡所构成的独立危险性。资料来源为在1983～1986年间进行的多中心地尔硫草心肌梗塞后试验,对象为安慰剂组的1234例确诊的急性心肌梗塞患者
In most post-MI myocardial infarction (MI) risk stratification and intervention trials, cardiogenic death is either alone or in combination with non-fatal myocardial infarction as the primary outcome endpoint, but nonfatal re-infarction is associated with subsequent cardiac arrest The risk posed by sex death lacks quantitative research. This article discusses the clinical determinants of cardigenic and non-fatal recanalization to determine the independent risk of non-fatal recanalisation for subsequent cardiogenic death. The data source was a post-multicenter Dulbecet’s myocardial infarction trial conducted between 1983 and 1986 in 1234 patients with confirmed acute myocardial infarction in the placebo group